Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Radiopharm Theranostics (NASDAQ:RADX) through any online brokerage.
There are no as such competitors for Radiopharm Theranostics.
Radiopharm Theranostics has a consensus price target of $15.33.
The stock price for Radiopharm Theranostics (NASDAQ: RADX) is $4.5496 last updated May 22, 2026 at 7:36 PM EDT.
There are no upcoming dividends for Radiopharm Theranostics.
Radiopharm Theranostics does not have any upcoming earnings scheduled.
There is no upcoming split for Radiopharm Theranostics.
Radiopharm Theranostics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.